Combining Novel Dual HIF Inhibitors with Immunotherapy Erases Multiple Tumor Types in Mice

Researchers developed novel, first-in-class drugs that inhibit both HIF-1 and HIF-2 and which, combined with immunotherapy, eliminated breast, colorectal, melanoma, and prostate tumors in mice, suggesting that the drugs could eventually be used to treat a broad range of cancers in humans.

The post Combining Novel Dual HIF Inhibitors with Immunotherapy Erases Multiple Tumor Types in Mice appeared first on GEN - Genetic Engineering and Biotechnology News.